Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06245187

Get With the Guidelines Atrial Fibrillation Registry

Get With The Guidelines-Atrial Fibrillation is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–125 year

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

Get With The Guidelines-Atrial Fibrillation was initiated in 2013 with over 88 U.S. hospitals participating is designed to assist hospital care teams in consistently providing the latest evidence-based treatment for their AFib patients. At the same time, it offers a means of monitoring the quality of AFib care in U.S. hospitals and building a database for continued research and further quality improvement.

Achievement measures tracked through Get With The Guidelines-Atrial Fibrillation:

  • ACEI/ARB at discharge for LVSD
  • Assessment of thromboembolic risk factors
  • Beta Blocker at discharge
  • Discharged on FDA-approved anticoagulation therapy
  • PT/INR planned follow-up
  • Statin at discharge in AF patients with CAD, CVA/TIA or PVD.

Quality measures tracked through Get With The Guidelines-Atrial Fibrillation:

  • Aldosterone antagonist at discharge
  • Atrial fibrillation patient education
  • Anticoagulation therapy education
  • CHA2DS2-VASC reported
  • Discharge heart rate <110bpm
  • Smoking cessation
  • Warfarin at discharge for valvular atrial fibrillation

Additional measures collected by Get With The Guidelines-Atrial Fibrillation can be viewed at: http://www.heart.org/idc/groups/heart-public/@private/@wcm/@hcm/@gwtg/documents/downloadable/ucm_451183.pdf

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients hospitalized with nonvalvular Atrial Fibrillation or Atrial Flutter

Exclusion criteria

  • Patients who do not have nonvalvular Atrial Fibrillation or Atrial Flutter
  • Patients under 18 years of age
  • Patients not admitted as inpatients.
  • Patients on comfort care only
  • Patients discharged to hospice.

Treatment and study plan

GWTG Atrial Fibrillation program

Other

Evidence based recommended therapies and counseling prior to hospital discharge.

Primary outcomes

  1. Cardiac Tamponade and/or Pericardiocentesis Following Ablation

    Time frame: 30 days

    Percent of patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days following ablation procedure.

Study contacts

Contact information is provided by the study sponsor or research team.

Amy Bennett, JD

CONTACT

[email protected]

214-706-2237

Christine Rutan

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

American Heart Association

Other

Registry information

Official study title

Get With the Guidelines-Atrial Fibrillation

Acronym: GWTG-AF

Important dates

Study start
2013
Primary completion
2040
Study completion
2040
First posted
Feb 7, 2024
Registry last updated
Jan 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.